Jeffrey Hafkin

Company: Otsuka

Job title: Senior Director

Seminars:

Shaping the Trajectory of Trials by Understanding the Benefits of Multicentre, Placebo-Controlled Studies for IgAN 3:30 pm

Understanding the pathogenesis of IgAN and why proliferation-inducing ligands could be an ideal target  Outlining the advantages of a phase 3 randomized controlled trial to assess the efficacy and safety for IgAN drug development Using eGFR and uPCR as surrogate endpoints and their capabilities to shorten clinical trialsRead more

day: Conference Day One

Panel Discussion: A Global Initiative: Increasing Collaborative Work to Unite Towards a Streamlined Trials Process 1:30 pm

Agreeing on samples and linked clinical data to decipher the relationship between the biomarker and clinical outcomes  Collecting patient databases by improving the global repository  Including study coordinators to aid in prioritising measurementsRead more

day: Conference Day One Track B PM

Panel Discussion: A Global Initiative: Increasing Collaborative Work to Unite Towards a Streamlined Trials Process 10:00 am

Agreeing on samples and linked clinical data to decipher the relationship between the biomarker and clinical outcomes  Collecting patient databases by improving the global repository  Including study coordinators to aid in prioritising measurementsRead more

day: Conference Day Two